ArticleBMC public health2025
Epidemiological characteristics of respiratory tract infections during and after the pandemic of COVID-19 from 2021 - 2023 in Shenzhen, southern China.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Rapid and actionable nasal-swab screening supports antimicrobial stewardship in patients with pneumonia: a prospective study.Antimicrobial resistance and infection control · 2025Trial
- Effectiveness of a comprehensive nursing prevention and control system for respiratory infections in fever clinics in the era of co-existence of multiple pathogens.Frontiers in public health · 2026Article
- Development and validation of a multi-platform LAMP system for rapid HAdV-3 and HAdV-7 detection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveIt is now understood that the COVID-19 pandemic and its associated containment measures have affected the epidemiology of other respiratory viruses. This study aimed to investigate respiratory pathogen infections in Shenzhen during and after the COVID-19 pandemic.
methodsA retrospective analysis was conducted on test data from 24,814 patients at Shenzhen Third People's Hospital between January 2021 and December 2023. The analysis focused on changes in detection rates, epidemiological characteristics, and clinical features of respiratory pathogens, including three viruses and eight bacteria.
resultsThe overall positivity rate for respiratory viruses increased after the COVID-19 epidemic (P < 0.05), whereas no significant difference was detected in the overall positivity rate of most respiratory bacteria. Notably, the detection rates of influenza A and B increased after the COVID-19 epidemic, with influenza A showing the most significant increase from 4.5 to 10.8% (P < 0.05). Conversely, the detection rates of PAE and MRSA decreased significantly (P < 0.05), whereas those of HIN and SMA increased significantly (P < 0.05). The seasonal patterns of influenza A changed markedly, with a shift in peak occurrence and extended periods of high positivity. The age distribution of infections also shifted, with adults showing higher detection rates after the pandemic than school-aged children and elderly individuals did.
conclusionThe removal of non-pharmaceutical interventions following the COVID-19 pandemic has significantly affected the epidemiological and seasonal patterns of certain respiratory pathogens in Shenzhen. These findings highlight the need for continuous surveillance of multiple respiratory pathogens and adaptive public health strategies in the post-pandemic era.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.